Emerging evidence suggests that novel cardiovascular risk factors are also deregulated in PCOS, with increased CRP [13,14], IL-6 [15,16], and TNF-α levels [17], as well as reduced adiponectin levels observed in both obese and non-obese women with PCOS [18,19]. This evidence concerns the gene CRP and polycystic ovary syndrome.